These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 15701735)

  • 1. Artemisinins.
    Woodrow CJ; Haynes RK; Krishna S
    Postgrad Med J; 2005 Feb; 81(952):71-8. PubMed ID: 15701735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artemisinins in malaria treatment in the UK.
    Drug Ther Bull; 2010 Nov; 48(11):129-32. PubMed ID: 21057033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous artesunate for the treatment of severe malaria.
    Hess KM; Goad JA; Arguin PM
    Ann Pharmacother; 2010; 44(7-8):1250-8. PubMed ID: 20551300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous artesunate for severe malaria.
    Prescrire Int; 2008 Aug; 17(96):168-70. PubMed ID: 19492495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
    Noedl H; Krudsood S; Chalermratana K; Silachamroon U; Leowattana W; Tangpukdee N; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Sriwichai S; Rowan J; Bhattacharyya H; Ohrt C; Knirsch C
    Clin Infect Dis; 2006 Nov; 43(10):1264-71. PubMed ID: 17051490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemether for severe malaria: a meta-analysis of randomized clinical trials.
    Pittler MH; Ernst E
    Clin Infect Dis; 1999 Mar; 28(3):597-601. PubMed ID: 10194084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.
    Ramharter M; Oyakhirome S; Klein Klouwenberg P; Adégnika AA; Agnandji ST; Missinou MA; Matsiégui PB; Mordmüller B; Borrmann S; Kun JF; Lell B; Krishna S; Graninger W; Issifou S; Kremsner PG
    Clin Infect Dis; 2005 Jun; 40(12):1777-84. PubMed ID: 15909266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of pediatric malaria in Africa: act at issue].
    Faucher JF; Missinou MA; Brasseur P
    Med Trop (Mars); 2006 Jun; 66(3):292-4. PubMed ID: 16924825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives on the mechanism of action of artemisinins.
    Golenser J; Waknine JH; Krugliak M; Hunt NH; Grau GE
    Int J Parasitol; 2006 Dec; 36(14):1427-41. PubMed ID: 17005183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance.
    Hastings I
    Trends Parasitol; 2011 Feb; 27(2):67-72. PubMed ID: 20971040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
    Checkley AM; Whitty CJ
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):199-204. PubMed ID: 17402835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of artesunate for the treatment of severe malaria.
    Lubell Y; Yeung S; Dondorp AM; Day NP; Nosten F; Tjitra E; Abul Faiz M; Yunus EB; Anstey NM; Mishra SK; Mohanty S; White NJ; Mills AJ
    Trop Med Int Health; 2009 Mar; 14(3):332-7. PubMed ID: 19187518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemisinin-based combination treatment of falciparum malaria.
    Nosten F; White NJ
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):181-92. PubMed ID: 18165491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.
    Vivas L; Rattray L; Stewart LB; Robinson BL; Fugmann B; Haynes RK; Peters W; Croft SL
    J Antimicrob Chemother; 2007 Apr; 59(4):658-65. PubMed ID: 17337512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls in new artemisinin-containing antimalarial drug development.
    Jambou R; Le Bras J; Randrianarivelojosia M
    Trends Parasitol; 2011 Feb; 27(2):82-90. PubMed ID: 21030307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance hampers our capacity to roll back malaria.
    Olliaro P
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S247-57. PubMed ID: 16032560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemisinins: activities and actions.
    Haynes RK; Krishna S
    Microbes Infect; 2004 Nov; 6(14):1339-46. PubMed ID: 15555542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. If artemisinin drugs fail, what's plan B?
    Enserink M
    Science; 2010 May; 328(5980):846. PubMed ID: 20466918
    [No Abstract]   [Full Text] [Related]  

  • 20. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.
    Gasasira AF; Kamya MR; Achan J; Mebrahtu T; Kalyango JN; Ruel T; Charlebois E; Staedke SG; Kekitiinwa A; Rosenthal PJ; Havlir D; Dorsey G
    Clin Infect Dis; 2008 Apr; 46(7):985-91. PubMed ID: 18444813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.